Company Overview
Snapshot
Founded in November 2000 by Ely Simon, NeuroTrax operates with 1–10 employees. The company has raised $1.5 million across one funding round from the New Jersey Economic Development Authority. In December 2007, NeuroTrax completed a $1.5 million funding round and announced the hiring of John Rooney as Chief Marketing Officer.
Business overview
NeuroTrax develops BrainCare, a cloud-based computer application designed for brain wellness. This platform offers a series of interactive tests and associated reports that enable clinicians to monitor brain fitness and provide data-driven recommendations for brain training. The company's technology assesses cognitive areas by measuring accuracy and response time, comparing results to both previous patient data and normative peer groups. NeuroTrax serves the healthcare industry, empowering patients, families, clinicians, and researchers with tools for brain health within the Digital Healthcare and Medical Decision Support sectors.
Strategic signal
In June 2014, NeuroTrax made its BrainCare platform globally available, specifically targeting brain wellness for individuals post-stroke and those with traumatic brain injury (TBI). This expansion signals the company's commitment to broadening access to its cognitive assessment technology and addressing critical needs in neurological rehabilitation and long-term brain health management on an international scale.
Log in to access full profile ›Company Intelligence Q&A
- What is NeuroTrax's primary product?
- NeuroTrax's primary product is BrainCare, a cloud-based computer application for brain wellness that includes a series of tests and reports for monitoring brain fitness and providing training recommendations.
- When was NeuroTrax founded?
- NeuroTrax was founded in November 2000.
- What significant funding event has NeuroTrax completed?
- In December 2007, NeuroTrax completed a $1.5 million funding round, with investment from the New Jersey Economic Development Authority.
- What was a key market expansion for NeuroTrax?
- In June 2014, NeuroTrax made its BrainCare platform available globally, targeting brain wellness for post-stroke and TBI patients.
- What recent research highlights the efficacy of cognitive testing?
- In February 2018, an article on Medscape highlighted how digital cognitive testing, such as that offered by NeuroTrax, can uncover hidden impairment in Multiple Sclerosis patients.